chr17-82051601-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002917.2(RFNG):c.166C>T(p.Arg56Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000296 in 1,282,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002917.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000100 AC: 15AN: 149640Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000203 AC: 23AN: 1133220Hom.: 0 Cov.: 32 AF XY: 0.00000909 AC XY: 5AN XY: 550026
GnomAD4 genome AF: 0.000100 AC: 15AN: 149746Hom.: 0 Cov.: 31 AF XY: 0.000109 AC XY: 8AN XY: 73156
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.166C>T (p.R56W) alteration is located in exon 1 (coding exon 1) of the RFNG gene. This alteration results from a C to T substitution at nucleotide position 166, causing the arginine (R) at amino acid position 56 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at